AAAAAA

   
Results: 1-13 |
Results: 13
ORGAN PRESERVATION AND SURVIVAL WITH SURGICAL-TREATMENT FOR LARYNX-CARCINOMA
Authors: ECKEL HE JUNGEHULSING M SCHRODER U VOSSING M DAMM M VOLLING P
Citation: He. Eckel et al., ORGAN PRESERVATION AND SURVIVAL WITH SURGICAL-TREATMENT FOR LARYNX-CARCINOMA, European journal of cancer, 33, 1997, pp. 1149-1149
EVALUATION OF MONOCLONAL-ANTIBODIES (PC-1 0, MIB-1, P53, LEUM1) FOR VALUE IN PROGNOSIS OF PATIENTS WITH SQUAMOUS CARCINOMA OF THE LARYNX FOLLOWING PARTIAL LASER RESECTION
Authors: HAKE R ECKEL H VONPRITZBUER E VOLLING P THIELE J
Citation: R. Hake et al., EVALUATION OF MONOCLONAL-ANTIBODIES (PC-1 0, MIB-1, P53, LEUM1) FOR VALUE IN PROGNOSIS OF PATIENTS WITH SQUAMOUS CARCINOMA OF THE LARYNX FOLLOWING PARTIAL LASER RESECTION, Der Pathologe, 16(3), 1995, pp. 197-203
TRANSORAL LASER RESECTION WITH STAGED DISCONTINUOUS NECK DISSECTION FOR ORAL CAVITY AND OROPHARYNX SQUAMOUS-CELL CARCINOMA
Authors: ECKEL HE VOLLING P POTOTSCHNIG C ZOROWKA P THUMFART W
Citation: He. Eckel et al., TRANSORAL LASER RESECTION WITH STAGED DISCONTINUOUS NECK DISSECTION FOR ORAL CAVITY AND OROPHARYNX SQUAMOUS-CELL CARCINOMA, The Laryngoscope, 105(1), 1995, pp. 53-60
PRELIMINARY-RESULTS OF A PROSPECTIVE RAND OMIZED TRIAL WITH INDUCTIONCHEMOTHERAPY FOR CANCER OF THE ORAL CAVITY AND PHARYNX
Authors: VOLLING P SCHRODER M
Citation: P. Volling et M. Schroder, PRELIMINARY-RESULTS OF A PROSPECTIVE RAND OMIZED TRIAL WITH INDUCTIONCHEMOTHERAPY FOR CANCER OF THE ORAL CAVITY AND PHARYNX, HNO. Hals-, Nasen-, Ohrenarzte, 43(2), 1995, pp. 58-64
INDUCTION CHEMOTHERAPY IN PRIMARY RESECTABLE HEAD AND NECK TUMORS - APROSPECTIVE RANDOMIZED TRIAL
Authors: VOLLING P SCHRODER M MULLER RP EBELING O QUIRIN R STENNERT E
Citation: P. Volling et al., INDUCTION CHEMOTHERAPY IN PRIMARY RESECTABLE HEAD AND NECK TUMORS - APROSPECTIVE RANDOMIZED TRIAL, International journal of oncology, 4(4), 1994, pp. 909-914
ACCELERATED SPLIT-COURSE RADIATION AND SIMULTANEOUS CHEMOTHERAPY IN PATIENTS WITH UNRESECTABLE HEAD AND NECK-CANCER
Authors: VOLLING P STAAR S ECKEL H STENNERT E ACHTERRATH W MULLER RP
Citation: P. Volling et al., ACCELERATED SPLIT-COURSE RADIATION AND SIMULTANEOUS CHEMOTHERAPY IN PATIENTS WITH UNRESECTABLE HEAD AND NECK-CANCER, International journal of oncology, 4(1), 1994, pp. 143-149
INCIDENCE AND PROGNOSIS OF MINOR SALIVARY -GLAND TUMORS
Authors: ECKEL HE SCHRODER U VOLLING P STENNERT E
Citation: He. Eckel et al., INCIDENCE AND PROGNOSIS OF MINOR SALIVARY -GLAND TUMORS, Laryngo-, Rhino-, Otologie, 73(9), 1994, pp. 461-471
RESULTS AFTER ACCELERATED RADIOTHERAPY AN D SIMULTANEOUS CARBOPLATINUM APPLICATION IN INOPERABLE CARCINOMAS OF THE HEAD AND NECK REGION
Authors: VOLLING P STAAR S ECKEL HE MULLER RP
Citation: P. Volling et al., RESULTS AFTER ACCELERATED RADIOTHERAPY AN D SIMULTANEOUS CARBOPLATINUM APPLICATION IN INOPERABLE CARCINOMAS OF THE HEAD AND NECK REGION, Laryngo-, Rhino-, Otologie, 73(10), 1994, pp. 511-517
RESULTS AFTER ACCELERATED RADIOTHERAPY AN D SIMULTANEOUS CARBOPLATINUM APPLICATION IN INOPERABLE CARCINOMAS OF THE HEAD AND NECK REGION
Authors: VOLLING P STAAR S ECKEL HE MULLER RP
Citation: P. Volling et al., RESULTS AFTER ACCELERATED RADIOTHERAPY AN D SIMULTANEOUS CARBOPLATINUM APPLICATION IN INOPERABLE CARCINOMAS OF THE HEAD AND NECK REGION, Laryngo-, Rhino-, Otologie, 73(10), 1994, pp. 511-517
HEAD AND NECK SQUAMOUS-CELL CARCINOMAS - CLINICAL RELEVANCE OF ONCOGENE AMPLIFICATIONS
Authors: JUNGEHULSING M VOLLING P
Citation: M. Jungehulsing et P. Volling, HEAD AND NECK SQUAMOUS-CELL CARCINOMAS - CLINICAL RELEVANCE OF ONCOGENE AMPLIFICATIONS, HNO. Hals-, Nasen-, Ohrenarzte, 42(5), 1994, pp. 280-287
A COMPARISON OF CISPLATIN 5-FU WITH CARBO PLATIN 5-FU FOR 5-YEAR SURVIVAL OF PATIENTS WITH SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
Authors: EBELING O ECKEL HE VOLLING P HEITMANN K VOSSING M
Citation: O. Ebeling et al., A COMPARISON OF CISPLATIN 5-FU WITH CARBO PLATIN 5-FU FOR 5-YEAR SURVIVAL OF PATIENTS WITH SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK, HNO. Hals-, Nasen-, Ohrenarzte, 42(10), 1994, pp. 629-635
A COMPARISON OF CISPLATIN 5-FU WITH CARBO PLATIN 5-FU FOR 5-YEAR SURVIVAL OF PATIENTS WITH SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
Authors: EBELING O ECKEL HE VOLLING P HEITMANN K VOSSING M
Citation: O. Ebeling et al., A COMPARISON OF CISPLATIN 5-FU WITH CARBO PLATIN 5-FU FOR 5-YEAR SURVIVAL OF PATIENTS WITH SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK, HNO. Hals-, Nasen-, Ohrenarzte, 42(10), 1994, pp. 629-635
ANALYSIS OF PROTOONCOGENES IN SQUAMOUS-CELL CARCINOMAS OF THE HEAD AND NECK (SCCHN)
Authors: VOLLING P JUNGEHULSING M STUTZER H DIEHL V TESCH H
Citation: P. Volling et al., ANALYSIS OF PROTOONCOGENES IN SQUAMOUS-CELL CARCINOMAS OF THE HEAD AND NECK (SCCHN), International journal of oncology, 3(4), 1993, pp. 671-677
Risultati: 1-13 |